Vitasoy International Holdings Limited filed its Monthly Return for Equity Issuer for the period ended 31 October 2026, highlighting a net reduction of 6.47 million ordinary shares through on-market repurchases and subsequent cancellation.
The company’s issued share capital (excluding treasury shares) declined to 1.01 billion shares from 1.02 billion at end-September, representing a 0.64 % contraction. All 6.47 million shares repurchased between 25 August and 20 October—comprising 1.41 million shares bought in October and 5.06 million acquired in late August and September—were formally cancelled on 30 October 2026 following shareholder approval granted on 24 August 2026.
Despite the reduction, Vitasoy confirmed compliance with the Main Board’s 25 % minimum public-float requirement as at 31 October 2026.
No new shares were issued during the month. All 27.65 million outstanding share options across schemes dated 2017-2026 remained unexercised; however, an aggregate 276,000 options under the 2023-2026 schemes were cancelled in October, lowering potential dilution. The company did not issue warrants, convertible securities, or treasury shares, and no funds were raised from option exercises during the month.
The latest share count adjustment reflects Vitasoy’s ongoing capital-management strategy while maintaining regulatory float thresholds.
Comments